End-stage Renal Disease
Conditions
Keywords
end-stage renal disease, renal replacement therapy
Brief summary
The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.
Interventions
OTHERrenal replacement therapy
renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )
Sponsors
Inje University
Study design
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No
Inclusion criteria
* The age of patient was between 18 yrs and 79 yrs. * The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization
Exclusion criteria
* The level of serum albumin was below 2.0 or over 5.0 * The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month. * The level of Body mass index was below 15 or over 30 * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy | During hospitalization | The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy | during hospitalization | The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011) |
Countries
South Korea
Outcome results
None listed